COX-2 and ALS

被引：3
|
作者：
McGeer, PL [1 ]
机构：
[1] Univ British Columbia, Kinsmen Lab Neurol Res, Vancouver, BC V5Z 1M9, Canada
来源：
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS | 2001年 / 2卷 / 03期
关键词：
D O I：
10.1080/146608201753275562
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：121 / 122
页数：2
相关论文
共 50 条
  • [21] COX-2 inhibitors
    Hawkey, CJ
    LANCET, 1999, 353 (9149): : 307 - 314
  • [22] COX-2 inhibition
    Varrassi, G
    Facchetti, G
    Marinangeli, F
    MANAGEMENT OF ACUTE AND CHRONIC PAIN: THE USE OF THE TOOLS OF THE TRADE, 2000, : 351 - 356
  • [23] COX-2 inhibitors
    Lawrie, MM
    MEDICAL JOURNAL OF AUSTRALIA, 2001, 174 (07) : 367 - 367
  • [24] COX-2 inhibitors
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1997, 2 (09) : 393 - 393
  • [25] Cox-2 confusion
    Peg Brickley
    Genome Biology, 4 (1)
  • [26] COX-2 on the brain
    Daniel Jones
    Nature Reviews Drug Discovery, 2003, 2 (6) : 423 - 423
  • [27] COX-2 as Neurotoxin
    不详
    CHEMICAL RESEARCH IN TOXICOLOGY, 2008, 21 (10) : 1915 - 1915
  • [28] Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors
    Debabrata Mukherjee
    Eric J Topol
    Arthritis Res Ther, 5
  • [29] Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial
    Luo, C
    He, ML
    Bohlin, L
    ACTA PHARMACOLOGICA SINICA, 2005, 26 (08) : 926 - 933
  • [30] Glycosylation of cyclooxygenase-2 (COX-2) influences effectiveness of COX-2 inhibitors
    Graham, Kamara Whitney
    Sevigny, Mary B.
    Gabriel, Bianca S.
    FASEB JOURNAL, 2009, 23
12345